SCHEMBL20166166

SCHEMBL20166166

CC(C)(C)[Si](C)(C)OC[C@H]1OC(=O)[C@](Cl)(Br)[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18549091 1.00 TOP2A (0.35) TOP2A
SCHEMBL19464443 0.86 TOP2A (0.37) TOP2A
SCHEMBL16777627 0.86 TOP2A (0.37) TOP2A
SCHEMBL17215151 0.84 TOP2A (0.35) TOP2A
SCHEMBL20789104 0.84 TOP2A (0.35) TOP2A
SCHEMBL18817574 0.84 TOP2A (0.35) TOP2A
SCHEMBL16777798 0.84 TOP2A (0.35) TOP2A
SCHEMBL18817224 0.84 TOP2A (0.35) TOP2A
SCHEMBL18815510 0.84 TOP2A (0.35) TOP2A
SCHEMBL14028075 0.81 TOP2A (0.37) TOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018093717-A1 COMPOSITIONS AND METHODS FOR TREATING HCV INFECTION ABBVIE INC. (US) 2018-05-24 WO disclosed